medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number 3

<< Back Next >>

Gac Med Mex 2004; 140 (3)

Giant cell glioblastoma. Case Report. Leonardo Álvarez-Betancourt, Salvador López-Ortega, Agustín Caldera-Duarte

Alvarez-Betancourt L, López-Ortega S, Caldera-Duarte A
Full text How to cite this article

Language: Spanish
References: 12
Page: 341-342
PDF size: 527.82 Kb.


Key words:

Glioblastomas, giant cells, intraventricular, paraventricular, prognosis.

ABSTRACT

Glioblastomas (World Health Organization, (WHO), grade IV) are the most frequent and malignant neoplasms of the human nervous system, Giant cells glioblastomas, a subtype of these, account for less than 1% of all brain toumors and up to 5% of glioblastomas. We present the case of a female who was diagnosed and treated for a right intra and paraventricular giant cell glioblastoma. We enfatize the importance of histological features of this toumor related to its prognosis.


REFERENCES

  1. Palma L, Di Lorenzo N, Guidetti B. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. J Neurosurg 49:854-861,1978.

  2. Burger P, Green S. Patient age, histologic features and length of survival in patients with glioblastoma multiforme. Cancer 59:1617-1625,1987.

  3. Margetts J, Kalyan-Raman U. Giant-celled glioblastoma of brain.Cancer. 63:524-531,1989.

  4. Winger MJ, Macdonald DR, Cairncross JG. Supratentorial anaplastic gliomas in adults. J Neurosurg 71:487-493,1989.

  5. Deimling A, Ammon Klaus, Schoenfeld D, Wiestler O,Seizinger BR, Louis DN: Subsets of glioblastoma multiforme defined by molecular genetic analysis.Brain Pathology 3:19-26,1993.

  6. Meyer-Puttlitz B,Hayashi Y, Waha A, Rollbrocker B, et al. Molecular genetic analysis of giant cell glioblastomas. Am Jour of Pathol 151:853-857,1997.

  7. Tohma Y, Gratas C,Biernat W, Peraud A et al. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57:684-689,1998.

  8. Kleihues P, Cavenee WK. Giant cell glioblastoma in Pathology and genetics of tumours of the nervous system, Editorial & Publications Service,Lyon France, July,1999.

  9. Berger MS, Wilson CB. Classification of the gliomas in The gliomas, W.B. Saunders Company,1999.

  10. Klein R, Mölenkamp G, Sörensen N, Roggendorf W. Favorable outcome of giant cell glioblastoma in a child. Child´s Nerv Syst 14:288-291,1998.

  11. Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system, 5th edn. Arnold, London pp237-240.

  12. Burger P, Green S. Patient age, histologic features and length of survival in patients with glioblastoma multiforme. Cancer 59:1617-1625,1987.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2004;140